Figure 1.
Molecular mechanisms of CTLA-4 and PD-1 inhibitory T-cell activation. Reprinted from “Blockade of CTLA-4 or PD-1 Signaling in Tumor Immunotherapy”, by BioRender.com (2022) (accessed on 6 March 2022). Retrieved from https://app.biorender.com/biorender-templates (accessed on 6 March 2022).